Syn Prop e Tech SA · BMFBOVESPA:SYNE3
Syn Prop e Tech SA — Grupo Biotoscana — Q1 2019 Earnings Presentation
14 slides from Syn Prop e Tech SA's earnings presentation, May 13, 2019
Slide 1: 1Q19 GBT Results Presentation
1Q19 GBT Results Presentation Montevideo, May 13th, 2019 B3: GBIO33
Slide 2: 1Q19 highlights
Message from management 1Q19 highlights Key takeaways 2019 Priorities ▪ Excellent performance of new launches – in-licensed and BGx products, contributing with 15% of total top line 2 ▪ Recently launched products (innovatives) up 209% QoQ, 1 Operational efficiency 3 demonstrating substantial improve
Slide 3: Profit and loss statement highlights
Key operating and financial results Profit and loss statement highlights 1Q19 1Q18 Chg. % 1Q19* 1Q19 Chg. % Gross revenues 162.3 212.9 -23.7% 163.4 183.5 -13.8% Net revenues 148.7 190.0 -21.7% 149.7 169.1 -11.0% Cost of goods sold -74.5 -83.5 -10.8% -69.6 -76.6 -8.3% COGS (%) -50.1% -43.9% 615 bps -
Slide 4: Continuous renewal of deal flow with potential partners
Further pipeline Continuous renewal of deal flow with potential partners Attractive- Business Due Attractive- Business Due Indication Region Closing Territory Indication Region Closing Territory ness Plan Diligence ness Plan Diligence ONCOLOGY ANTI INFECTIVES R/R CLL, iNHL US Latin America cUTI US L
Slide 5: Net revenues breakdown
Net revenues Net revenues breakdown 1Q19 Portfolio breakdown (BRL million | % growth compared to 1Q18) 136% -3% -83% 209% -10% -11% 190.0 1.7 -0.9 -21% -22% -23.7 -12.1 169.1 14.2 -19.4 149.7 -1.0 148.7 1Q18 Discontinued Licenses BGx launches Peak year Mature products 1Q19 FX 1Q19* Hyperinflation 1Q
Slide 6: Net revenues breakdown
Net revenues Net revenues breakdown 1Q19 Net revenues by country (BRL million | % growth compared to 1Q18) -68% 8% -26% 190.0 -5.7 4.3 -13% 19% -11% 88% -20.8 -3.5 3.6 169.1 -21% -22% 1.3 -19.4 149.7 -1.0 148.7 1Q18 Sovaldi Brazil Argentina Colombia Mexico Others 1Q19 FX 1Q19* Hyperinflation 1Q19 Ar
Slide 7: Operating expenses
Opex Operating expenses Expenses (BRL million) 1Q19 1Q18 Chg. % 1Q19* 1Q19 Chg. % Selling and marketing expenses -30.8 -31.9 -3.2% -30.8 -34.2 7.4% Recurring general and administrative expenses -21.7 -22.0 -1.2% -21.4 -23.5 6.9% (+) Stock grants -0.3 -2.8 -88.9% -0.3 -0.3 -88.9% G&A expenses includi
Slide 8: EBITDA and net financial expenses
Financials EBITDA and net financial expenses 1Q19 EBITDA breakdown (BRL million) -34% constant growth 2.8 2.6 48.2 42.8 43.6 -16.6 12.3 -10.5 33.1 31.7 -0.3 -5.4 27.7 EBITDA Stock grants One-timers Adjusted Growth Adjusted Stock grants One-timers EBITDA FX EBITDA Hyperinflation EBITDA 1Q18 1Q18 1Q18
Slide 9: Effective tax rate and adjusted net income
Financials Effective tax rate and adjusted net income Effective tax rate (BRL million) 1Q18 2Q18 3Q18 4Q18 1H18 2H18 2018 1Q19 EBT 23.8 28.3 16.9 26.1 52.0 43.0 95.0 13.0 Current income tax -8.4 -8.2 -6.4 -0.7 -16.6 -7.1 -23.7 -3.1 Deferred income tax 0.6 -0.1 -1.4 -6.9 0.5 -8.3 -7.8 -1.9 Total inco
Slide 10: Net cash flow and working capital highlights
Financials Net cash flow and working capital highlights Net cash flow from operating activities Cash conversion cycle (BRL million) (Days) 1Q19 1Q18 1Q18 2Q18 3Q18 4Q18 1Q19 Net cash flow from operations activities -2.6 9.1 Days sales outstanding 140 107 156 102 134 Adjusted net cash flow from opera
Slide 11: Net indebtedness
Financials Net indebtedness Net debt / adjusted EBITDA¹ Adjusted EBITDA / interest expense¹ Debt reconciliation (BRL million) Total debt 1Q19 237.6 5.9x 6.0x Cash -75.3 1.0x Net debt 1Q19 162.3 0.6x 4Q18 1Q19 4Q18 1Q19 Debt overview as of March 31, 2019 (BRL million) 48.3 237.6 185.7 3.6 Total debt
Slide 12: Shareholders base
Capital markets Shareholders base Breakdown at the time of IPO Breakdown as of March 31, 2019 Free float | Top 20 shareholders (% of free float) (% of free float) (% of total free float) Others Latin America Others Latin America 3% 15% 0% 5% Europe United States United States Europe 2% 32% 19% 12% A
Slide 13: Disclaimer
Disclaimer This presentation may contain forward-looking statements. Such statements are not statements of historical facts and reflect the beliefs and expectations of the Company’s management. The words “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “plans”, “predicts”, “project”,
Slide 14: IR Contact
IR Contact Melissa Angelini ir@grupobiotoscana.com +55 11 5090-5927 14